Physician profile
Anna Kupriyeva
NPI 1275776981
$230.24
in general payments reported to CMS, 2019-2025
8 companies · $59.83 in 2025
The $59.83 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.60 · 2020: $64.42 · 2024: $79.39 · 2025: $59.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $139.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hartmann USA, INC. | $40.20 | 2024 | Colactive Plus 2x2, Zetuvit Plus 10x10 P10 |
| Stryker Corporation | $39.46 | 2020 | |
| Smith+Nephew, INC. | $39.19 | 2024 | Collagenase Santyl |
| Melinta Therapeutics, LLC | $26.60 | 2019 | |
| Advanced Oxygen Therapy INC. | $24.96 | 2020 | |
| Bioventus LLC | $23.31 | 2025 | Exogen Ultrasound Bone Healing System |
| Cashflow Solutions, LLC | $19.99 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Tactile Systems Technology INC | $16.53 | 2025 | Nimbl, Flexitouch Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Kupriyeva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.